{
    "id": "15953",
    "title": "Multiplex awarded contract for Moderna mRNA facility",
    "slug": "multiplex-awarded-contract-for-moderna-mrna-facility",
    "excerpt": "Melbourne is one step closer to having a new mRNA vaccine manufacturing facility, after Multiplex was awarded the construction contract by Moderna.",
    "featuredImage": "https://cdn-01.cms-ap-v2i.applyflow.com/building-environs/wp-content/uploads/2023/03/Multiplex-awarded-contract-for-Moderna-mRNA-facility.jpg",
    "imageAlt": "Melbourne is one step closer to having a new mRNA vaccine manufacturing facility, after Multiplex was awarded the construction contract by Moderna.",
    "publishDate": "2023-03-10",
    "author": "Building Environs",
    "category": "construction",
    "readTime": "3 min read",
    "content": {
      "sections": [
        {
          "type": "hero_image",
          "src": "https://cdn-01.cms-ap-v2i.applyflow.com/building-environs/wp-content/uploads/2023/03/Multiplex-awarded-contract-for-Moderna-mRNA-facility.jpg",
          "alt": "Melbourne is one step closer to having a new mRNA vaccine manufacturing facility, after Multiplex was awarded the construction contract by Moderna.",
          "caption": "Image credit: Multiplex",
          "layout": "full_width",
          "width": "800px",
          "height": "448px"
        },
        {
          "type": "paragraph",
          "content": "Melbourne is one step closer to having a new mRNA vaccine manufacturing facility, after [Multiplex](https://www.multiplex.global/au/) was awarded the construction contract by Moderna.",
          "layout": "full_width"
        },
        {
          "type": "paragraph",
          "content": "The facility will be located within the [Monash Technology Precinct](https://www.monash.edu/industry/monash-technology-precinct), and will be the first of its kind in the southern hemisphere. It's being established under a 10-year partnership between Moderna, and the Victorian and Australian governments.",
          "layout": "full_width"
        },
        {
          "type": "paragraph",
          "content": "Designed by Greenbox, CRB and IPS, the facility will house pharmaceutical-grade space – including Drug Substance (DS) and Drug Product (DP) areas – within its 16,500 square metres. Additional features include laboratories, a warehouse with loading dock, and extensive outdoor landscaping.",
          "layout": "full_width"
        },
        {
          "type": "paragraph",
          "content": "Moderna's new facility will be able to produce COVID vaccines – as well as mRNA vaccines for a variety of other respiratory illnesses. Importantly, it will supply Australia with its own onshore mRNA manufacturing capability in the event of a new pandemic.",
          "layout": "full_width"
        },
        {
          "type": "paragraph",
          "content": "Construction is due to be completed in 2024.",
          "layout": "full_width"
        },
        {
          "type": "centered_content",
          "content": "**Want more planning and construction news?**",
          "layout": "full_width"
        },
        {
          "type": "bold_text",
          "content": "[Visit our news and articles page.](https://www.buildingenvirons.com.au/news/)",
          "layout": "full_width"
        }
      ]
    }
  }